Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)
Financial Results:
Biocon Ltd reported Revenues for Q4FY24 of ₹3,917.00 Crores up from ₹3,774.00 Crore year on year, a rise of 3.79%.
Total Expenses for Q4FY24 of ₹3,638.00 Crores up from ₹3,430.00 Crores year on year, a rise of 6.06%.
Consolidated Net Profit of ₹223.00 Crores down 46.14% from ₹414.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.13, down 56.70% from ₹2.61 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.